Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Schizophrenia Research|July 13, 2013
How to compare doses of different antipsychotics: a systematic review of methodsMaxine X Patel, Ioli A Arista, Mark Taylor, et al.
Therapeutic Advances in Psychopharmacology|October 30, 2013
Plasma quetiapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2000-2011Simon A Handley, Sally V J Bowskill, Maxine X Patel, et al.
Human Psychopharmacology|September 22, 2012
Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010Sally V J Bowskill, Maxine X Patel, Simon A Handley, et al.
International Clinical Psychopharmacology|June 18, 2004
Prognostic indicators for early discontinuation of risperidone long-acting injectionMaxine X Patel, Corina Young, Chiara Samele, et al.
Journal of Clinical Psychopharmacology|April 24, 2013
Olanzapine: a systematic review and meta-regression of the relationships between dose, plasma concentration, receptor occupancy, and responseDelia Bishara, Olubanke Olofinjana, Anna Sparshatt, et al.
The American Journal of Psychiatry|March 3, 2011
A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophreniaJari Tiihonen, Jari Haukka, Mark Taylor, et al.
The American Journal of Psychiatry|December 17, 2019
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute SchizophreniaStefan Leucht, Alessio Crippa, Spyridon Siafis, et al.
Therapeutic Drug Monitoring|January 4, 2014
Psychiatrists' perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoringLauren Best-Shaw, Maria Gudbrandsen, Jessica Nagar, et al.
The Journal of Clinical Psychiatry|April 29, 2015
The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health servicesCarol Paton, Michael J Crawford, Sumera F Bhatti, et al.
Pageof 4